Modern cancer therapy has seen a revolution with the advent of targeted drugs, which offer more precise treatment with potentially fewer side effects than traditional chemotherapy. Erlotinib hydrochloride stands as a prime example – a tyrosine kinase inhibitor that targets specific genetic mutations in cancer cells. The effectiveness and availability of such advanced therapies hinge on the reliable production of their constituent chemical intermediates.
One such critical intermediate is 4,5-Bis(2-methoxyethoxy)-2-nitrobenzonitrile (CAS: 236750-65-5). This compound is not a drug itself, but rather a fundamental building block in the complex multi-step synthesis of Erlotinib. Its precise chemical structure, with its nitro and nitrile functionalities, is engineered to participate in specific reactions that ultimately lead to the formation of the active pharmaceutical ingredient (API). Without high-purity intermediates like this, the synthesis of Erlotinib would be significantly more challenging, costly, and potentially less successful.
The journey from basic chemicals to a life-saving drug involves numerous stages, each requiring specialized knowledge and rigorous quality control. The manufacturers of these intermediates play a crucial, albeit often unseen, role. For pharmaceutical companies, sourcing reliable suppliers for intermediates like 4,5-Bis(2-methoxyethoxy)-2-nitrobenzonitrile is a strategic imperative. It ensures not only the quality of the final drug but also the stability of the supply chain. This is where our role as a dedicated manufacturer and supplier of high-purity pharmaceutical intermediates becomes indispensable.
The demand for advanced cancer therapies continues to grow, underscoring the importance of the entire pharmaceutical supply chain, from raw material suppliers to API manufacturers. By providing high-quality 4,5-Bis(2-methoxyethoxy)-2-nitrobenzonitrile, we contribute directly to making targeted cancer treatments like Erlotinib more accessible to patients worldwide. If your organization is involved in the research, development, or manufacturing of Erlotinib, partnering with a dependable supplier for this vital intermediate is a critical step towards achieving your goals.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.